Benzinga's Top Initiations By: Benzinga via Benzinga January 28, 2016 at 09:53 AM EST Analysts at Janney Capital initiated coverage on Nektar Therapeutics (NASDAQ: NKTR) with a Buy rating. Nektar Therapeutics shares ... Read More >> Related Stocks: Bioblast Pharma Ltd Comscore Inc Instructure Holdings Inc Nektar Therapeutics Par Pacific Holdings Inc Pure Storage Inc